Bortezomib induces apoptosis in T lymphoma cells and natural killer lymphoma cells independent of Epstein-Barr virus infection

Genome-Wide siRNA Screen for Modulators of Cell Death Induced by Proteasome Inhibitor Bortezomib

(2010) Siquan Chen et al.   CANCER RESEARCH

How I treat EBV lymphoproliferation

(2009) H. E. Heslop   BLOOD

Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in cutaneous T cell lymphoma

(2009) Ulrike Heider et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

NF- B Activation Through the Alternative Pathway Correlates with Chemoresistance and Poor Survival in Extranodal NK/T-cell Lymphoma, Nasal Type

(2009) X. Liu et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Tubacin Kills Epstein-Barr Virus (EBV)-Burkitt Lymphoma Cells by Inducing Reactive Oxygen Species and EBV Lymphoblastoid Cells by Inducing Apoptosis

(2009) Junichi Kawada et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Priming of protective T cell responses against virus-induced tumors in mice with human immune system components

(2009) Till Strowig et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Quantitative analysis of Epstein-Barr virus (EBV)-related gene expression in patients with chronic active EBV infection

(2009) S. Iwata et al.   JOURNAL OF GENERAL VIROLOGY

Identification of Epstein‐Barr Virus (EBV)–Infected Lymphocyte Subtypes by Flow Cytometric In Situ Hybridization in EBV‐Associated Lymphoproliferative Diseases

(2009) Hiroshi Kimura et al.   JOURNAL OF INFECTIOUS DISEASES

Antileukemic activity of valproic acid in chronic lymphocytic leukemia B cells defined by microarray analysis

(2009) B Stamatopoulos et al.   LEUKEMIA

The Presence or Absence of Latent Epstein-Barr Virus Does Not Alter the Sensitivity of Burkitt’s Lymphoma Cell Lines to Proteasome Inhibitors

(2008) Cory Cordova et al.   ACTA HAEMATOLOGICA

Phase I study of proteasome inhibitor bortezomib plus CHOP in patients with advanced, aggressive T-cell or NK/T-cell lymphoma

(2008) J. Lee et al.   ANNALS OF ONCOLOGY

Epstein–Barr virus renders the infected natural killer cell line, NKL resistant to doxorubicin-induced apoptosis

(2008) Y Isobe et al.   BRITISH JOURNAL OF CANCER

A New Humanized Mouse Model of Epstein‐Barr Virus Infection That Reproduces Persistent Infection, Lymphoproliferative Disorder, and Cell‐Mediated and Humoral Immune Responses

(2008) Misako Yajima et al.   JOURNAL OF INFECTIOUS DISEASES

Cell death by bortezomib-induced mitotic catastrophe in natural killer lymphoma cells

(2008) L. Shen et al.   MOLECULAR CANCER THERAPEUTICS

One-step multiplex real-time PCR assay to analyse the latency patterns of Epstein-Barr virus infection

(2007) Naomi Kubota et al.   JOURNAL OF VIROLOGICAL METHODS